Inspire Medical Systems, Inc. Common Stock (INSP)
R&D to Revenue
12.31%
Quarterly · Period ending:
INSP R&D to Revenue
Latest reported12.31%period ending
Latest reported12.31%period ending
INSP Quarterly R&D/Revenue (30.07% → 12.31%)
Latest values, visible window
High-resolution chart · PNG
INSP r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 12.3132% | |
| 12.6237% | |
| 9.2695% | |
| 10.7844% | |
| 12.0731% | |
| 13.8106% | |
| 12.6549% | |
| 12.8367% | |
| 14.7326% | |
| 17.5904% | |
| 16.1302% | |
| 19.0108% | |
| 20.3988% | |
| 19.9528% | |
| 15.4083% | |
| 19.2265% | |
| 15.904% | |
| 17.1082% | |
| 13.1304% | |
| 15.5856% | |
| 17.5381% | |
| 20.2072% | |
| 15.8339% | |
| 20.3867% | |
| 49.7579% | |
| 25.4743% | |
| 14.0006% | |
| 17.3665% | |
| 15.7831% | |
| 16.0185% | |
| 12.996% | |
| 13.5667% | |
| 15.8621% | |
| 17.2276% | |
| 16.8926% | |
| 16.1738% | |
| 28.8481% | |
| 30.0736% |